Detalhe da pesquisa
1.
Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.
Proc Natl Acad Sci U S A
; 115(6): E1147-E1156, 2018 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29351990
2.
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming.
J Hepatol
; 72(6): 1159-1169, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31954205
3.
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma.
Front Oncol
; 12: 941552, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36203462
4.
Potential role of two novel agonists of thyroid hormone receptor-ß on liver regeneration.
Cell Prolif
; 53(5): e12808, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32347601
5.
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis.
Cancers (Basel)
; 12(8)2020 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32824383
6.
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF.
Cancer Cell
; 35(4): 573-587.e6, 2019 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30975481